Mobile Menu - OpenMobile Menu - Closed

Hearing on “Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Costs”

Date: 
Tuesday, April 2, 2019 - 10:30am
Continuations: 
Tuesday, April 2, 2019 - 10:30am
Location: 
2322 Rayburn House Office Building

The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce held a hearing on Tuesday, April 2, 2019, at 10:30 a.m. in room 2322 of the Rayburn House Office Building. The hearing is entitled, “Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Costs.” 

 

Live Stream

 

Key Documents

Memorandum from Chairman Pallone to the Subcommittee on Oversight and Investigations 

Opening Statement of Chairman Pallone as prepared for delivery

Opening Statement of Subcommittee Chair DeGette as prepared for delivery

 

Witnesses

Gail deVore
Patient Advocate
Coloradan living with Type 1 diabetes for 47 years

Testimony


William T. Cefalu, M.D.
Chief Scientific, Medical & Mission Officer
American Diabetes Association (ADA)

Testimony


Alvin C. Powers, M.D.
Endocrine Society Representative
Director, Vanderbilt Diabetes Center
Director, Division of Diabetes, Endocrinology, and Metabolism
Vanderbilt University Medical Center

Testimony


Kasia J. Lipska, M.D.
Yale-New Haven Hospital Center for Outcomes Research and Evaluation
Yale University School of Medicine

Testimony


Christel Marchand Aprigliano, M.S.
Chief Executive Officer
Diabetes Patient Advocacy Coalition (DPAC)

Testimony


Aaron J. Kowalski, Ph.D.
Chief Mission Officer
JDRF

Testimony

 

Issues: